bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
0.2943
-0.0035 (-1.18%)
At close: Jun 11, 2025, 4:00 PM
0.2820
-0.0123 (-4.18%)
Pre-market: Jun 12, 2025, 6:19 AM EDT
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $8.10 million as of June 12, 2025. Its market cap has decreased by -71.75% in one year.
Market Cap
8.10M
Enterprise Value
8.99M
1-Year Change
-71.75%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $45.03M to $8.10M, a decrease of -82.01%. That is a compound annual growth rate of -46.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2025 | 8.20M | -42.19% |
| Dec 31, 2024 | 14.18M | 1.50% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.26% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 725.92B |
| Johnson & Johnson | 373.57B |
| Novo Nordisk | 353.21B |
| AbbVie | 338.27B |
| UnitedHealth Group | 281.72B |
| Abbott Laboratories | 235.37B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |